Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's Revision tag was updated from v3.5.3 to v3.5.4, indicating a minor backend/template update rather than any changes to the study details or user-facing information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision tag, v3.5.3, has been added to the page, replacing the previous v3.5.2. This reflects a small front-end/system update to the page rendering and metadata surrounding the study details, with no changes to the study content.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.2 added and v3.5.0 removed.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.5.0 is now shown in the page footer, replacing the previous label. The prior Revision: v3.4.3 label has been removed.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check105 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1, and the funding-status notice has been removed.SummaryDifference0.5%

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.